Progression of head and neck squamous cell cancer

被引:0
|
作者
József Tímár
Orsolya Csuka
Éva Remenár
Gábor Répássy
Miklós Kásler
机构
[1] National Institute of Oncology,Department of Oto
[2] Semmelweis University,Rhyno
来源
关键词
head and neck cancer; invasion marker; lymphatic metastasis;
D O I
暂无
中图分类号
学科分类号
摘要
Squamous cell cancer in the head and neck region (HNSC) is unique concerning its progression since it remains locoregional for long time and visceral metastases develop only in a later stage of the disease. Accordingly, molecular markers of the local invasion and the lymphatic dissemination both have critical importance. HNSC progression is associated with deregulated control of cell proliferation and apoptosis but it seems equally significant the disregulation of the proteolytic machineries. Here we outline the lymphatic metastatic cascade for HNSC to depict key molecular determinants as possible prognostic factors or therapeutic targets identifying immunological selection as a major feature. Unlike in local spreading, invasive potential of cancer cells seems to be less significant during lymphatic dissemination due to the anatomical properties of the lymphatic vessels and tissues. There is a general believe that HNSC is one disease however, data indicate that the anatomical localization of the tumor (the “soil”) such as oral, lingual, glottic or pharyngeal has a significant effect on the gene expression profile and corresponding biological behavior of HNSC. Furthermore, even the endocrine milieu of the host was proved to be influential in modulating the progression of HNSC. Gene expression profiling techniques combined with proteomics could help to define and select usefull genetic and biomarkers of progression of HNSC, some of them could well be potential novel therapeutic target.
引用
收藏
页码:107 / 127
页数:20
相关论文
共 50 条
  • [1] Progression of head and neck squamous cell cancer
    Tímár, J
    Csuka, O
    Remenár, É
    Répássy, G
    Kásler, M
    CANCER AND METASTASIS REVIEWS, 2005, 24 (01) : 107 - 127
  • [2] Head and neck squamous cell cancer
    Tryggvason, Geir
    Sveinsson, Porarinn E.
    Hjartarson, Hannes
    Halfdanarson, Porvarour R.
    LAEKNABLADID, 2009, 95 (10): : 671 - 680
  • [3] Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer
    Mithani, Suhail K.
    Taube, Janis M.
    Zhou, Shaoyu
    Smith, Ian M.
    Koch, Wayne M.
    Westra, William H.
    Califano, Joseph A.
    CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4331 - 4335
  • [4] Molecular progression of head and neck squamous cell carcinoma
    Saha S.K.
    Maiti G.P.
    Roychoudhury S.
    Panda C.K.
    The Nucleus, 2017, 60 (2) : 111 - 119
  • [5] Docetaxel in squamous cell cancer of the head and neck
    Posner, MR
    ANTI-CANCER DRUGS, 2001, 12 : S21 - S24
  • [6] Squamous cell head and neck cancer in nonsmokers
    Tan, EH
    Adelstein, DJ
    Droughton, MLT
    VanKirk, MA
    Lavertu, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (02): : 146 - 150
  • [7] Cetuximab and the Head and Neck Squamous Cell Cancer
    Concu, Riccardo
    Cordeiro, M. Natalia D. S.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (03) : 192 - 198
  • [8] Immunotherapy in Head and Neck Squamous Cell Cancer
    Denaro, Nerina
    Merlano, Marco Carlo
    CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY, 2018, 11 (04) : 217 - 223
  • [9] ITGAV Promotes the Progression of Head and Neck Squamous Cell Carcinoma
    Xu, Lingyi
    Barrett, Jeremy G.
    Peng, Jiayi
    Li, Suk
    Messadi, Diana
    Hu, Shen
    CURRENT ONCOLOGY, 2024, 31 (03) : 1311 - 1322
  • [10] Cancer stem cells in head and neck squamous cell cancer
    Prince, Mark E. P.
    Ailles, Laurie E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (17) : 2871 - 2875